GE HealthCare is expected to announce Monday a $945 million cash purchase of a manufacturer of radioactive substances used in medical imaging procedures like PET scans

The deal expands GE HealthCare's footprint in radiopharmaceuticals, its fastest-growing segment.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。